DLA Piper has expanded its national Emerging Growth and Venture Capital practice through the addition of Partner Sarah Chambless, who will be based in the firm’s Los Angeles office. The appointment strengthens one of the world’s most active legal platforms for advising high-growth companies and venture capital investors.
Chambless brings a substantial track record advising emerging-growth and venture capital-backed companies, as well as their investors, across corporate, financing, and mergers-and-acquisitions matters. Her work spans corporate governance, venture capital financings, cross-border investments, strategic acquisitions, joint ventures, and secondary transactions. She focuses on technology and life sciences companies at various stages of development.
Her client portfolio includes a wide range of high-growth and late-stage companies across sectors such as aerospace, defense, dual-use technologies, digital health, consumer products, and media.
The hire arrives as DLA Piper continues to grow its position in the global venture ecosystem. The firm’s Emerging Growth and Venture Capital practice now includes more than 200 lawyers delivering strategic counsel to emerging companies and venture firms across technology, healthcare, life sciences, and financial services.
Over the past three years, the practice has completed more than 2,100 global financings totaling over $80 billion.
KEY QUOTE:
“Sarah is adept at guiding companies through complex challenges in the technology and life sciences sectors,” said Jeffrey Lehrer, Chair of DLA Piper’s Emerging Growth and Venture Capital practice. “She will be a true asset to clients navigating today’s rapidly evolving landscape.”
Jeffrey Lehrer, Chair, Emerging Growth And Venture Capital Practice, DLA Piper
